Suda Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
2,060.90
3,378.30
2,286.80
1,238.30
-
Depreciation, Depletion & Amortization
67.10
181.20
122.40
124.20
-
Other Funds
-
-
36.00
-
-
Funds from Operations
1,565.70
2,830.90
1,589.10
897.40
2,548.00
Changes in Working Capital
1,048.90
323.50
213.00
43.20
-
Net Operating Cash Flow
2,614.60
3,154.40
1,802.10
854.20
2,548.00
Capital Expenditures
2,004.00
1,278.20
1,461.60
1,307.20
908.10
Sale of Fixed Assets & Businesses
-
5.50
38.60
-
1,584.40
Purchase/Sale of Investments
-
-
647.10
-
-
Net Investing Cash Flow
2,004.00
1,272.80
2,070.10
1,307.20
676.30
Issuance/Reduction of Debt, Net
1,900.00
-
105.00
72.50
-
Net Financing Cash Flow
7,844.80
6,689.80
69.00
1,482.50
200.00
Net Change in Cash
3,237.80
2,261.60
3,803.20
679.00
1,671.70
Free Cash Flow
2,903.00
3,436.80
1,867.40
938.80
2,616.30
Change in Capital Stock
5,944.80
6,689.80
-
1,410.00
-
Exchange Rate Effect
11.60
1.10
-
-
-

About Suda

View Profile
Address
55 Howe Street
Osborne Park Western Australia (WA) 6017
Australia
Employees -
Website http://www.sudapharma.com
Updated 07/08/2019
Suda Pharmaceuticals Ltd. develops pharmaceuticals and distributes medical devices and consumables. Its activities include pharmaceutical development of drug delivery technology and medical devices and consumables distribution. The company operates through following segment: Suda, Westcoast Surgical and Medical Supplies; and Malaria Research Company.